The effectiveness of topical applications varies depending on the type and stage of cancer. For instance, 5-FU is highly effective in treating actinic keratosis and superficial basal cell carcinoma. Imiquimod has shown success in treating superficial basal cell carcinoma and actinic keratosis. The success rate often depends on the patient's compliance with treatment protocols and the specific characteristics of the tumor.
